Optimal selection of RuO 2 for durable oxygen evolution reactions in acidic media by continuous regulation of Ru–O covalency
Energy & Environmental Science · 2025 · 18 (9) · 4200-4209
DOI: 10.1039/d4ee04861j ↗Kurz gefasst
Fachartikel in der Zeitschrift Energy & Environmental Science, 2025. Verfasst von Xintong Li und 7 weiteren Autor:innen. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Data Center of Management Science, National Natural Science Foundation of China - Peking University, National Natural Science Foundation of China, Beijing Synchrotron Radiation Facility.
Abstract (Originalsprache)
We obtained excellent activity and stability at high current densities by continuously doping Cr while successively modulating the electron transfer capacity of the catalyst as well as the Ru–O covalency.
Förderung
- Data Center of Management Science, National Natural Science Foundation of China - Peking University
- National Natural Science Foundation of China
- Beijing Synchrotron Radiation Facility
Zitieren
APA
Li, X., Chen, G., Liu, Y., Lu, R., Ma, C., Wang, Z., Han, Y., & Wang, D. (2025). Optimal selection of RuO 2 for durable oxygen evolution reactions in acidic media by continuous regulation of Ru–O covalency. Energy & Environmental Science, 18(9), 4200-4209. https://doi.org/10.1039/d4ee04861j
Vancouver
Li X, Chen G, Liu Y, Lu R, Ma C, Wang Z, et al. Optimal selection of RuO 2 for durable oxygen evolution reactions in acidic media by continuous regulation of Ru–O covalency. Energy & Environmental Science. 2025;18(9):4200-4209. doi:10.1039/d4ee04861j
BibTeX
@article{Li2025,
author = {Li, Xintong and Chen, Guanzhen and Liu, Yan and Lu, Ruihu and Ma, Chao and Wang, Ziyun and Han, Yunhu and Wang, Dingsheng},
title = {Optimal selection of RuO 2 for durable oxygen evolution reactions in acidic media by continuous regulation of Ru–O covalency},
journal = {Energy & Environmental Science},
year = {2025},
volume = {18},
number = {9},
pages = {4200--4209},
doi = {10.1039/d4ee04861j}
}
EUVIMED